This provider's $65.4M in total Medicare payments ranks in the 99th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 573% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $144.08 | $41.48 | 3.47x | $102.60 | $3.8M | 92.0K | 121 |
| 2015 | $198.49 | $72.63 | 2.73x | $125.86 | $3.6M | 48.9K | 89 |
| 2016 | $185.98 | $61.38 | 3.03x | $124.60 | $2.8M | 46.3K | 76 |
| 2017 | $192.39 | $56.04 | 3.43x | $136.35 | $2.8M | 49.6K | 59 |
| 2018 | $229.56 | $72.23 | 3.18x | $157.33 | $3.4M | 46.6K | 48 |
| 2019 | $243.61 | $71.66 | 3.40x | $171.95 | $2.9M | 40.7K | 53 |
| 2020 | $124.57 | $95.63 | 1.30x | $28.94 | $19.6M | 205.0K | 59 |
| 2021 | $93.02 | $59.00 | 1.58x | $34.02 | $15.9M | 270.0K | 62 |
| 2022 | $151.27 | $74.21 | 2.04x | $77.06 | $7.1M | 95.9K | 56 |
| 2023 | $344.27 | $119.68 | 2.88x | $224.59 | $3.5M | 29.0K | 56 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 348.0K | $30.4M | $87.29 | 1.15x |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 209.1K | $10.4M | $49.76 | 3.39x |
| 81479 | Molecular pathology procedure | 3.0K | $7.3M | $2.5K | 1.29x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 130.9K | $3.3M | $24.97 | 1.00x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 985 | $2.0M | $2.1K | 1.40x |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | 26.9K | $2.0M | $73.49 | 2.29x |
| 81256 | Gene analysis (hemochromatosis) common variants | 24.8K | $1.8M | $73.56 | 5.54x |
| 81450 | Targeted genomic sequence analysis panel of dna or combine dna and rna of 5-50 genes associated with blood and lymphatic system disorders | 2.1K | $1.6M | $749.07 | 5.69x |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | 17.0K | $877.8K | $51.76 | 2.64x |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | 10.3K | $716.7K | $69.57 | 3.26x |
| 88360 | Microscopic genetic analysis of tumor, manual | 6.0K | $464.9K | $77.13 | 3.66x |
| 81432 | Test for detecting genes associated with inherited breast cancer-related disorders | 571 | $457.1K | $800.44 | 4.43x |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | 7.8K | $454.7K | $58.63 | 3.83x |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 1.1K | $321.4K | $301.54 | 2.96x |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 936 | $206.1K | $220.22 | 6.54x |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | 1.0K | $147.1K | $141.22 | 1.39x |
| 82677 | Estriol (hormone) level | 4.5K | $133.9K | $29.99 | 4.48x |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | 6.1K | $133.8K | $22.06 | 3.13x |
| 81241 | Gene analysis (coagulation factor v) leiden variant | 1.5K | $122.0K | $81.50 | 3.97x |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 861 | $121.2K | $140.74 | 1.90x |
This provider submits charges 2.09 times higher than what Medicare actually pays.
A markup ratio of 2.09x means for every $100 Medicare pays, this provider initially charges $209. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Burlington, NC | $2.2B | ⚠️ Flagged |
| Pathgroup Labs, Llc | Greensboro, NC | $203.7M | ⚠️ Flagged |
| Mako Medical Laboratories, Llc | Raleigh, NC | $107.0M | ✓ Clear |
| Quest Diagnostics Clinical Laboratories Inc | Greensboro, NC | $69.3M | ⚠️ Flagged |
| Laboratory Corporation Of America Holdings | Research Triangle Park, NC | $61.5M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data